medRxiv
Liver fat accumulation contributes to discordant genetic risk between coronary artery disease and type 2 diabetes
Preprint: Mendelian randomisation in 378,772 peopleMechanisms
Declared ties to: AstraZeneca, Bayer, Biogen and 5 more
Abstract
BackgroundType 2 diabetes (T2D) and coronary artery disease (CAD) frequently co-occur, yet the biological pathways that jointly determine risk remain incompletely understood.
- Causal inference
- Human genetics
- Lipid and ceramide metabolism
- Liver fat content
- Coronary artery disease
- Humans
The paper
University of Cambridge
medRxiv, 26 Aug 2026, CC BY, Preprint, not peer-reviewed
